SCHEMBL26080871

SCHEMBL26080871

CC(C)/C(C(=O)O)=C(/F)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
HTR2A P28223 1/20 0.42
HRH1 P35367 1/20 0.42
KCNH2 Q12809 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
XBP1 P17861 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
ELANE P08246 1/20 0.40
CES1 P23141 5/20 0.39
CES2 O00748 4/20 0.39
TSHR P16473 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9709284 0.78 CYP2C9 (0.44) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL9709278 0.78 CYP2C9 (0.44) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL1173261 0.78 PGR (0.43) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL10586436 0.77 RAB9A (0.36) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL4617145 0.73 SMN1; SMN2 (0.45) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL13505417 0.73 PGR (0.47) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL17847697 0.72 CES1 (0.48) SMN1; SMN2MAPTLMNAALDH1A1HPGD
Toluene SCHEMBL1083282 0.72 LMNA (0.50) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL4188899 0.72 CES1 (0.48) SMN1; SMN2MAPTLMNAATMALDH1A1
SCHEMBL8724219 0.72 CES1 (0.48) SMN1; SMN2MAPTLMNAATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230314934-A1 PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230314934-A1 PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS CRY1, CBR3, C1S PGR 436/4885ADRA2A 2375/4885ADRA2B 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.